The Trump Administration has promised not to cut Medicare and Medicaid benefits but that doesn’t mean it’s been leaving ...

The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

The Centers for Medicare and Medicaid Services said late Friday that it would not cover medications such as Wegovy that are ...

Kennedy Jr., has been an outspoken opponent of the injectable drugs, which have exploded in popularity due to the potentially ...

The Trump administration has decided against expanding coverage to allow certain drugs to be used for weight loss in the case ...

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Legislation passed in 2003 prohibits Medicare, the federal health program for adults 65 and older, from covering medication solely for weight loss. But under President Biden, CMS had proposed ...

Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through ...

Popular weight loss drugs may do more than curb appetite — they may also help reduce the risk of dementia, according to new research.